PFCS
XFOR icon

Pale Fire Capital SE’s X4 Pharmaceuticals XFOR Stock Holding History

Pale Fire Capital SE’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-167,590
Closed -$692K – 83
2026
Q1 		$692K Hold
167,590
– – 0.06% 32
2025
Q4 		$670K Sell
167,590
-13,261
-7% -$48.2K 0.05% 35
2025
Q3 		$619K Buy
180,851
+120,800
+201% +$312K 0.07% 31
2025
Q2 		$114K Sell
60,051
-7,794
-11% -$31.9K 0.01% 53
2025
Q1 		$481K Buy
67,845
+21,113
+45% +$291K 0.06% 31
2024
Q4 		$1.03M Sell
46,732
-6,694
-13% -$107K 0.23% 19
2024
Q3 		$1.07M Buy
53,426
+47,525
+805% +$992K 0.17% 26
2024
Q2 		$103K Buy
5,901
+4,632
+365% +$151K 0.01% 38
2024
Q1 		$52.9K Buy
+1,269
New +$35.3K 0.01% 50

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pale Fire Capital SE's XFOR Position: Q2 2026 in Review

Pale Fire Capital SE sold out of X4 Pharmaceuticals (XFOR) in Q2 2026, closing a stake of 167,590 shares — an estimated $692K sold.

Pale Fire Capital SE first reported a position in XFOR in Q1 2024 and held it in 9 quarters. The position peaked at $1.07M in Q3 2024. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Pale Fire Capital SE reported no remaining X4 Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Pale Fire Capital SE sold 167,590 X4 Pharmaceuticals shares in Q2 2026, an estimated $692K.
  • Pale Fire Capital SE first reported a position in X4 Pharmaceuticals in Q1 2024 and held it in 9 quarters.
  • Pale Fire Capital SE's X4 Pharmaceuticals position peaked at $1.07M in Q3 2024.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.